Cargando…

High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer

Detalles Bibliográficos
Autores principales: Pichler, Renate, Loidl, Wolfgang, Pichler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323287/
https://www.ncbi.nlm.nih.gov/pubmed/30687612
http://dx.doi.org/10.21037/tau.2018.08.15
_version_ 1783385732777246720
author Pichler, Renate
Loidl, Wolfgang
Pichler, Martin
author_facet Pichler, Renate
Loidl, Wolfgang
Pichler, Martin
author_sort Pichler, Renate
collection PubMed
description
format Online
Article
Text
id pubmed-6323287
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-63232872019-01-25 High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer Pichler, Renate Loidl, Wolfgang Pichler, Martin Transl Androl Urol Editorial AME Publishing Company 2018-12 /pmc/articles/PMC6323287/ /pubmed/30687612 http://dx.doi.org/10.21037/tau.2018.08.15 Text en 2018 Translational Andrology and Urology. All rights reserved.
spellingShingle Editorial
Pichler, Renate
Loidl, Wolfgang
Pichler, Martin
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
title High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
title_full High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
title_fullStr High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
title_full_unstemmed High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
title_short High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
title_sort high economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323287/
https://www.ncbi.nlm.nih.gov/pubmed/30687612
http://dx.doi.org/10.21037/tau.2018.08.15
work_keys_str_mv AT pichlerrenate higheconomicburdenofimmunotherapyunderlinestheneedofpredictivebiomarkersfortheindividualtherapyalgorithminmetastaticbladdercancer
AT loidlwolfgang higheconomicburdenofimmunotherapyunderlinestheneedofpredictivebiomarkersfortheindividualtherapyalgorithminmetastaticbladdercancer
AT pichlermartin higheconomicburdenofimmunotherapyunderlinestheneedofpredictivebiomarkersfortheindividualtherapyalgorithminmetastaticbladdercancer